Literature DB >> 2272143

Topography of Alzheimer's neurofibrillary change distribution in myotonic dystrophy.

N Yoshimura1, M Otake, K Igarashi, M Matsunaga, K Takebe, H Kudo.   

Abstract

Histological changes that explain the mental symptoms of patients with myotonic dystrophy (MD) have not fully been demonstrated yet. Recently, the presence of Alzheimer's neurofibrillary changes (ANCs) in the brain have been reported in this disease. We studied the brain of a 61-year-old male with MD. The distribution of ANCs was investigated and mapped through careful histological examinations. The examinations disclosed that in MD, ANCs distributed along their preferential sites of the brain; a great number of ANCs were found in the parahippocampus, hippocampus, amygdaloid nucleus, fusiform gyrus, insula, and olfactory bulb, many in the nucleus basalis of Meynert, inferior temporal gyrus, hypothalamus, and brain stem, and a few in the cingulate, frontal and temporal gyri, neostriatum, and mammillary body. In the brain stem, ANCs were seen in the central gray, oculomotor nucleus, linear nucleus, substantia nigra, locus coeruleus, dorsal raphe nucleus, superior central nucleus, retriculotegmental nucleus, and reticular formation. From this result and the previous reports by others, it may be suggested that the presence of ANCs concentrated mostly in the limbic system is a regular and significant histological finding in the brain in MD. Therefore, this limbic lesion must be related to some of the mental symptoms unique to MD. In addition, diffuse and considerable neuronal atrophy and gliosis in the thalami in the absence of ANCs also may have played a causative role in some of the mental symptoms of the present case. Besides the more concentrated occurrence of ANCs within the limbic system, the minimal presence of senile plaques in the CNS may differentiate the brain in MD from that in Alzheimer-type dementia.

Entities:  

Mesh:

Year:  1990        PMID: 2272143

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  10 in total

1.  Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities.

Authors:  Antonio Giorgio; Maria T Dotti; Marco Battaglini; Silvia Marino; Marzia Mortilla; Maria L Stromillo; Placido Bramanti; Alfredo Orrico; Antonio Federico; Nicola De Stefano
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

2.  Genome modification leads to phenotype reversal in human myotonic dystrophy type 1 induced pluripotent stem cell-derived neural stem cells.

Authors:  Guangbin Xia; Yuanzheng Gao; Shouguang Jin; S H Subramony; Naohiro Terada; Laura P W Ranum; Maurice S Swanson; Tetsuo Ashizawa
Journal:  Stem Cells       Date:  2015-06       Impact factor: 6.277

3.  Generation of neural cells from DM1 induced pluripotent stem cells as cellular model for the study of central nervous system neuropathogenesis.

Authors:  Guangbin Xia; Katherine E Santostefano; Marianne Goodwin; Jilin Liu; S H Subramony; Maurice S Swanson; Naohiro Terada; Tetsuo Ashizawa
Journal:  Cell Reprogram       Date:  2013-04       Impact factor: 1.987

4.  Magnetic resonance imaging of muscle and brain in myotonic dystrophy.

Authors:  M S Damian; G Bachmann; D Herrmann; W Dorndorf
Journal:  J Neurol       Date:  1993-01       Impact factor: 4.849

5.  Epiretinal membrane: a treatable cause of visual disability in myotonic dystrophy type 1.

Authors:  Hannah M Kersten; Richard H Roxburgh; Nicholas Child; Philip J Polkinghorne; Chris Frampton; Helen V Danesh-Meyer
Journal:  J Neurol       Date:  2013-10-17       Impact factor: 4.849

Review 6.  Monoaminergic neuropathology in Alzheimer's disease.

Authors:  Goran Šimić; Mirjana Babić Leko; Selina Wray; Charles R Harrington; Ivana Delalle; Nataša Jovanov-Milošević; Danira Bažadona; Luc Buée; Rohan de Silva; Giuseppe Di Giovanni; Claude M Wischik; Patrick R Hof
Journal:  Prog Neurobiol       Date:  2016-04-12       Impact factor: 11.685

Review 7.  Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.

Authors:  Marie-Laure Caillet-Boudin; Francisco-Jose Fernandez-Gomez; Hélène Tran; Claire-Marie Dhaenens; Luc Buee; Nicolas Sergeant
Journal:  Front Mol Neurosci       Date:  2014-01-09       Impact factor: 5.639

8.  Genome-wide identification of microRNA-related variants associated with risk of Alzheimer's disease.

Authors:  Mohsen Ghanbari; M Arfan Ikram; Hans W J de Looper; Albert Hofman; Stefan J Erkeland; Oscar H Franco; Abbas Dehghan
Journal:  Sci Rep       Date:  2016-06-22       Impact factor: 4.379

Review 9.  Human iPSC Models to Study Orphan Diseases: Muscular Dystrophies.

Authors:  Guangbin Xia; Naohiro Terada; Tetsuo Ashizawa
Journal:  Curr Stem Cell Rep       Date:  2018-10-04

10.  Brain Structural Features of Myotonic Dystrophy Type 1 and their Relationship with CTG Repeats.

Authors:  Ellen van der Plas; Mark J Hamilton; Jacob N Miller; Timothy R Koscik; Jeffrey D Long; Sarah Cumming; Julija Povilaikaite; Maria Elena Farrugia; John McLean; Ravi Jampana; Vincent A Magnotta; Laurie Gutmann; Darren G Monckton; Peggy C Nopoulos
Journal:  J Neuromuscul Dis       Date:  2019
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.